[1]
Aronoff SL, Berkowitz K, Shreiner B, Want L. Glucose metabolism and regulation: Beyond insulin and glucagon. Diabetes Spectr 2004; 17(3): 183-90.
[2]
Barros RPA, Gabbi C, Morani A, Warner M, Gustafsson J-A. Participation of ER and ER in glucose homeostasis in skeletal muscle and white adipose tissue. AJP Endocrinol Metab 2009; 297(1): E124-33.
[3]
Seino Y, Nanjo K, Tajima N, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 2010; 1(5): 212-28.
[4]
American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes 2015; 33(2): 97-111.
[5]
Teixeira-Lemos E, Nunes S, Teixeira F, Reis F. Regular physical exercise training assists in preventing type 2 diabetes development: Focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 2011; 10(1): 12.
[6]
Blonde L. Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus. Am J Med 2010; 123(3)(Suppl.): S12-8.
[7]
Shepherd PR, Kahn BB. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341(4): 248-57.
[8]
Thompson D, Karpe F, Lafontan M, Frayn K. Physical activity and exercise in the regulation of human adipose tissue physiology. Physiol Rev 2012; 92(1): 157-91.
[9]
Liese AD, Ma X, Maahs DM, Trilk JL. Physical activity, sedentary behaviors, physical fitness, and their relation to health outcomes in youth with type 1 and type 2 diabetes: A review of the epidemiologic literature. J Sport Health Sci 2013; 2(1): 21-38.
[10]
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013; 93(1): 137-88.
[11]
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014; 383(9911): 69-82.
[12]
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539-53.
[13]
Casanova L, Hughes FJ, Preshaw PM. Diabetes and periodontal disease: a two-way relationship. Br Dent J 2014; 217(8): 433-7.
[14]
Fazeli Farsani S, van der Aa MP, van der Vorst MMJ, Knibbe CAJ, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: A systematic review and evaluation of methodological approaches. Diabetologia 2013; 56(7): 1471-88.
[15]
Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: Perspectives on the past, present, and future. Lancet (London, England) 2014; 383(9922): 1068-83.
[16]
Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol 2012; 8(4): 228-36.
[17]
Jia G, Aroor AR, DeMarco VG, Martinez-Lemus LA, Meininger GA, Sowers JR. Vascular stiffness in insulin resistance and obesity. Front Physiol 2015; 6(231): 1-8.
[18]
Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab 2016; 20(4): 546-51.
[19]
Buysman EK, Liu F, Hammer M, Langer J. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study. Adv Ther 2015; 32(4): 341-55.
[20]
Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: A global systematic review. Pharmacoeconomics 2015; 33(8): 811-31.
[21]
Turi BC, Monteiro HL, Fernandes RA, Codogno JS. The impact of physical activity on mitigation of health care costs related to diabetes mellitus: Findings from developed and developing settings Diabetes mellitus and physical exercise. Curr Diabetes Rev 2016; 12(4): 307-11.
[22]
Chen Y, Liu L, Gu L, Babineaux S, Colclough H, Curtis B. Glycemic control in chinese patients with type 2 diabetes mellitus receiving oral antihyperglycemic medication-only or insulin-only treatment: A cross-sectional survey. Diabetes Ther 2015; 6(2): 197-211.
[23]
Divino V, DeKoven M, Hallinan S, et al. Glucagon-like peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six european countries. Diabetes Ther 2014; 5(2): 499-520.
[24]
Stevens JW, Khunti K, Harvey R, et al. Preventing the progression to type 2 diabetes mellitus in adults at high risk: A systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract 2015; 107(3): 320-31.
[25]
Yardley JE, Sigal RJ. Exercise strategies for hypoglycemia prevention in individuals with type 1 diabetes. Diabetes Spectr 2015; 28(1): 32-8.
[26]
Zaharieva DP, Riddell MC. Prevention of exercise-associated dysglycemia: A case study-based approach. Diabetes Spectr 2015; 28(1): 55-62.
[27]
Shahar J, Hamdy O. Medication and exercise interactions: considering and managing hypoglycemia risk. Diabetes Spectr 2015; 28(1): 64-7.
[28]
Bally L, Laimer M, Stettler C. Exercise-associated glucose metabolism in individuals with type 1 diabetes mellitus. Curr Opin Clin Nutr Metab Care 2015; 18(4): 428-33.
[29]
Cuenca-García M, Jago R, Shield JPH, Burren CP. How does physical activity and fitness influence glycaemic control in young people with Type 1 diabetes? Diabet Med 2012; 29(10): e369-76.
[30]
Bohn B, Herbst A, Pfeifer M, et al. Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: A cross-sectional multicenter study of 18,028 patients. Diabetes Care 2015; 38(8): 1536-43.
[31]
Schweiger B, Klingensmith G, Snell-Bergeon JK. Physical activity in adolescent females with type 1 diabetes. Int J Pediatr 2010; 2010: 328318.
[32]
Prior SJ, Goldberg AP, Ortmeyer HK, et al. Increased skeletal muscle capillarization independently enhances insulin sensitivity in older adults after exercise training and detraining. Diabetes 2015; 64(10): 3386-95.
[33]
Stanford KI, Middelbeek RJW, Goodyear LJ. Exercise effects on white adipose tissue: Beiging and metabolic adaptations. Diabetes 2015; 64(7): 2361-8.
[34]
Cornell S. Continual evolution of type 2 diabetes: An update on pathophysiology and emerging treatment options. Ther Clin Risk Manag 2015; 11: 621-32.
[35]
Böhm A, Weigert C, Staiger H, Häring H-U. Exercise and diabetes: relevance and causes for response variability. Endocrine 2016; 51(3): 390-401.
[36]
Franz MJ, Zhang Z, Venn BJ. Lifestyle Interventions to Stem the Tide of Type 2 Diabetes. In: Nutrition Guide for Physicians and Related Healthcare Professionals. Cham: Springer International Publishing 2017; pp. 103-12.
[37]
Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. effects of exercise on glycemic control and body mass in type 2 diabetes mellitus. JAMA 2001; 286(10): 1218.
[38]
Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: Joint position statement. Diabetes Care 2010; 33(12): e147-67.
[39]
Martin W, Palazzo C, Poiraudeau S. Development and preliminary psychometrics of the exercise therapy burden questionnaire for patients with chronic conditions. Arch Phys Med Rehabil 2017; 98(11): 2188-2195.e6.
[40]
Schneider KL, Panza E, Handschin B, et al. Feasibility of pairing behavioral activation with exercise for women with type 2 diabetes and depression: The get it study pilot randomized controlled trial. Behav Ther 2016; 47(2): 198-212.
[41]
Gallé F, Di Onofrio V, Cirella A, et al. Improving self-management of type 2 diabetes in overweight and inactive patients through an educational and motivational intervention addressing diet and physical activity: A prospective study in Naples, South Italy. Diabetes Ther 2017; 8(4): 875-86.
[42]
Hordern MD, Dunstan DW, Prins JB, Baker MK, Singh MAF, Coombes JS. Exercise prescription for patients with type 2 diabetes and pre-diabetes: A position statement from exercise and sport science australia. J Sci Med Sport 2012; 15(1): 25-31.
[43]
Qiu S-H, Sun Z-L, Cai X, Liu L, Yang B. Improving patients’ adherence to physical activity in diabetes mellitus: A review. Diabetes Metab J 2012; 36(1): 1-5.
[44]
Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C. Physical activity/exercise and type 2 diabetes. Diabetes Care 2004; 27(10): 2518-39.
[45]
Lehnen AM, Leguisamo NM, Pinto GH, et al. The beneficial effects of exercise in rodents are preserved after detraining: a phenomenon unrelated to GLUT4 expression. Cardiovasc Diabetol 2010; 9(67): 1-8.
[46]
Zorzano A, Palacín M, Gumà A. Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle. Acta Physiol Scand 2005; 183(1): 43-58.
[47]
Viñals F, Ferré J, Fandos C, et al. Cyclic adenosine 3′,5′-monophosphate regulates GLUT4 and GLUT1 glucose transporter expression and stimulates transcriptional activity of the GLUT1 promoter in muscle cells. Endocrinology 1997; 138(6): 2521-9.
[48]
Wright DC, Hucker KA, Holloszy JO, Han DH. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 2004; 53(2): 330-5.
[49]
Jensen TE, Sylow L, Rose AJ, et al. Contraction-stimulated glucose transport in muscle is controlled by AMPK and mechanical stress but not sarcoplasmatic reticulum Ca(2+) release. Mol Metab 2014; 3(7): 742-53.
[50]
O’Neill HM. AMPK and exercise: glucose uptake and insulin sensitivity. Diabetes Metab J 2013; 37(1): 1-21.
[51]
McGee SL, Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression: Molecular mechanisms. Clin Exp Pharmacol Physiol 2006; 33(4): 395-9.
[52]
Gomes RJ, Leme JAC de A, de Moura LP, et al. Growth factors and glucose homeostasis in diabetic rats: effects of exercise training. Cell Biochem Funct 2009; 27(4): 199-204.
[53]
Kim T, Chang JS, Kim H, Lee KH, Kong ID. Intense walking exercise affects serum IGF-1 and IGFBP3. J Lifestyle Med 2015; 5(1): 21-5.
[54]
Hocking S, Samocha-Bonet D, Milner K-L, Greenfield JR, Chisholm DJ. Adiposity and insulin resistance in humans: The role of the different tissue and cellular lipid depots. Endocr Rev 2013; 34(4): 463-500.
[55]
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444(7121): 840-6.
[56]
Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004; 89(2): 463-78.
[57]
Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9(5): 367-77.
[58]
Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 2013; 36(8): 2175-82.
[59]
Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 2003; 26(11): 2977-82.
[60]
Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, Campbell LV. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 2004; 27(2): 629-30.
[61]
Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7(8): 941-6.
[62]
Bruun JM, Helge JW, Richelsen B, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006; 290(5): E961-7.
[63]
Hussey SE, McGee SL, Garnham A, Wentworth JM, Jeukendrup AE, Hargreaves M. Exercise training increases adipose tissue GLUT4 expression in patients with type 2 diabetes. Diabetes Obes Metab 2011; 13(10): 959-62.
[64]
Sanchez-Delgado G, Martinez-Tellez B, Olza J, Aguilera CM, Gil Á, Ruiz JR. Role of exercise in the activation of brown adipose tissue. Ann Nutr Metab 2015; 67(1): 21-32.
[65]
Castillo-Quan JI. From white to brown fat through the PGC-1α-dependent myokine irisin: Implications for diabetes and obesity. Dis Model Mech 2012; 5(3): 293-5.
[66]
Röhling M, Herder C, Stemper T, Müssig K. Influence of acute and chronic exercise on glucose uptake. J Diabetes Res 2016; 2016: 2868652.
[67]
Younk LM, Mikeladze M, Tate D, Davis SN. Exercise-related hypoglycemia in diabetes mellitus. Expert Rev Endocrinol Metab 2011; 6(1): 93-108.
[68]
American Diabetes Association. 4. Lifestyle Management: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41(Suppl. 1): S38-50.
[69]
Dahjio Y, Noubiap JJN, Azabji-Kenfack M, et al. Impact of a 12-week aerobic exercise training program on anthropometric and metabolic parameters of a group of type 2 diabetes Cameroonian women aged ≥50 years. Ann Transl Med 2016; 4(19): 364-4.
[70]
Lukács A, Barkai L. Effect of aerobic and anaerobic exercises on glycemic control in type 1 diabetic youths. World J Diabetes 2015; 6(3): 534-42.
[71]
Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the american diabetes association. Diabetes Care 2016; 39(11): 2065-79.
[72]
AminiLari Z, Fararouei M, Amanat S, et al.. The effect of 12 weeks aerobic, resistance, and combined exercises on omentin-1 levels and insulin resistance among type 2 diabetic middle-aged women. Diabetes Metab J 2017; 41(3): 205-12.
[73]
Jang HC. Sarcopenia, frailty, and Diabetes in Older Adults. Diabetes Metab J 2016; 40(3): 182-9.
[74]
Marzetti E, Calvani R, Tosato M, et al. Physical activity and exercise as countermeasures to physical frailty and sarcopenia. Aging Clin Exp Res 2017; 29(1): 35-42.